Search
Filters
Clear All
  • 12
  • 47
  • 2
  • 675

Phase

  • 1
  • 11
  • 11
  • 48
  • 9
  • 51
  • 6
  • 567
  • 668
  • 313

Found 736 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RADY-GU-SAYKIN-TLC; Older breast cancer patients: Risk for cognitive decline

A
Andrew Saykin, PsyD
60-100 years
Female
We are looking for healthy women (who have never had cancer) to participate in a study of at Indiana University School of Medicine. We are working to better understand cognitive changes after breast cancer treatment.
Learn More

A RANDOMIZED OPEN-LABEL ACTIVE CONTROLLED SAFETY AND EXTRAPOLATED EFFICACY STUDY IN PEDIATRIC SUBJECTS REQUIRING ANTICOAGULATION FOR THE TREATMENT OF A VENOUS THROMBOEMBOLIC EVENT

K
Kerry Hege, MD
12-18 years
All genders
The purpose of this research study is to assess the safety and efficacy of apixaban (which is a new anti-clotting drug) in the treatment of these blood clots in children.
Learn More

SURG-DUKE-CEPPA-VAC; A Randomized Phase II Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site Infection in Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery

E
Eugene Ceppa, MD
18-100 years
All genders
The purpose of this study is to compare the rate of surgical site infection between traditional wound care and negative pressure wound therapy.
Learn More

A Phase III International Randomized Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent

S
S. Hamid Sayer, MD
18-81 years
All genders
The study's primary objective [in a population of patients with MDS after failure of treatment with azacitidine (AZA) or decitabine (DAC)], is to compare the overall survival (OS) of patients in the rigosertib group vs the Physician's Choice group, in all patients and in a subgroup of patients with IPSS-R …
Learn More

VERY INTENSIVE VARIABLE REPETITIVE AMBULATION TRAINING (VIVRANT)

T
T. George Hornby
30-85 years
All genders
The purpose of this study is to investigate the effectiveness of three different walking training interventions on the recovery of strength, mobility, walking and other measures of health in individuals.
Learn More

Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

S
Shadia Jalal, MD
18-100 years
All genders
This randomized phase III trial studies how well erlotinib hydrochloride compared to placebo works in treating patients with stage IB-IIIA non-small cell lung cancer that has been completely removed by surgery.
Learn More

Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-small Cell Lung Cancers

S
Shadia Jalal, MD
18-100 years
All genders
This randomized phase III trial studies how well nivolumab after surgery and chemotherapy work in treating patients with stage IB-IIIA non-small cell lung cancer.
Learn More

A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver

M
Mark Tann, MD
18-100 years
All genders
The primary question of interest is quantifying the relationship between Y-90 liver therapy and liver damage.
Learn More

Dopamine and Smoking Behaviors

K
Karmen Yoder
18-55 years
All genders
The purpose of this study is to understand how and where brain dopamine reacts while you smoke a cigarette.
Learn More

Biomarkers of endothelial dysfunction in pediatric patients receiving high intensity chemotherapy/irradiation

J
Jodi Skiles
18 years and younger
All genders
The purpose of this study is to collect blood specimens and data from patients undergoing stem cell transplant.
Learn More
291 - 300 of 736